Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Eckmann

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Inflammatory Bowel Diseases|June 12, 2018
Implementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel DiseaseChristopher J Tyler, Tamara Pérez-Jeldres, Erik Ehinger, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2025
Inhibitors of the 20S proteasome β5 subunit as potent and selective agents against <i>Trichomonas vaginalis</i>Yukiko Miyamoto, Brianna M Hurysz, Pavla Fajtova, et al.
Inflammatory Bowel Diseases|December 30, 2014
Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's diseaseBrigid S Boland, David L Boyle, William J Sandborn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2013
Trp53 deficiency protects against acute intestinal inflammationMartina E Spehlmann, Carolin F Manthey, Sara M Dann, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Development of subunit selective substrates for <i>Trichomonas vaginalis</i> proteasomePavla Fajtova, Brianna M Hurysz, Yukiko Miyamoto, et al.
Eukaryotic Cell|May 22, 2007
Use of recombinant Entamoeba histolytica cysteine proteinase 1 to identify a potent inhibitor of amebic invasion in a human colonic modelSamuel G Meléndez-López, Scott Herdman, Ken Hirata, et al.
Journal of Hepatology|December 13, 2021
The fecal mycobiome in non-alcoholic fatty liver diseaseMünevver Demir, Sonja Lang, Phillipp Hartmann, et al.
Plos One|July 24, 2008
Nod2 mediates susceptibility to Yersinia pseudotuberculosis in miceUlrich Meinzer, Sophie Esmiol-Welterlin, Frederick Barreau, et al.
Diabetes|May 31, 2023
Loss of cAMP Signaling in CD11c Immune Cells Protects Against Diet-Induced ObesityLiping Zeng, D Scott Herdman, Sung Min Lee, et al.
The Journal of Clinical Investigation|May 13, 2025
Activation of intestinal endogenous retroviruses by alcohol exacerbates liver diseaseNoemí Cabré, Marcos F Fondevila, Wenchao Wei, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Inflammatory Bowel Diseases|June 12, 2018
Implementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel DiseaseChristopher J Tyler, Tamara Pérez-Jeldres, Erik Ehinger, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2025
Inhibitors of the 20S proteasome β5 subunit as potent and selective agents against <i>Trichomonas vaginalis</i>Yukiko Miyamoto, Brianna M Hurysz, Pavla Fajtova, et al.
Inflammatory Bowel Diseases|December 30, 2014
Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's diseaseBrigid S Boland, David L Boyle, William J Sandborn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2013
Trp53 deficiency protects against acute intestinal inflammationMartina E Spehlmann, Carolin F Manthey, Sara M Dann, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Development of subunit selective substrates for <i>Trichomonas vaginalis</i> proteasomePavla Fajtova, Brianna M Hurysz, Yukiko Miyamoto, et al.
Eukaryotic Cell|May 22, 2007
Use of recombinant Entamoeba histolytica cysteine proteinase 1 to identify a potent inhibitor of amebic invasion in a human colonic modelSamuel G Meléndez-López, Scott Herdman, Ken Hirata, et al.
Journal of Hepatology|December 13, 2021
The fecal mycobiome in non-alcoholic fatty liver diseaseMünevver Demir, Sonja Lang, Phillipp Hartmann, et al.
Plos One|July 24, 2008
Nod2 mediates susceptibility to Yersinia pseudotuberculosis in miceUlrich Meinzer, Sophie Esmiol-Welterlin, Frederick Barreau, et al.
Diabetes|May 31, 2023
Loss of cAMP Signaling in CD11c Immune Cells Protects Against Diet-Induced ObesityLiping Zeng, D Scott Herdman, Sung Min Lee, et al.
The Journal of Clinical Investigation|May 13, 2025
Activation of intestinal endogenous retroviruses by alcohol exacerbates liver diseaseNoemí Cabré, Marcos F Fondevila, Wenchao Wei, et al.
Pageof 17